Literature DB >> 26636387

Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.

Jie Zhang1, Dong-Xiao Zhuang1, Cheng-Jun Yao1, Ching-Po Lin2, Tian-Liang Wang3, Zhi-Yong Qin1, Jin-Song Wu1.   

Abstract

OBJECT The extent of resection is one of the most essential factors that influence the outcomes of glioma resection. However, conventional structural imaging has failed to accurately delineate glioma margins because of tumor cell infiltration. Three-dimensional proton MR spectroscopy ((1)H-MRS) can provide metabolic information and has been used in preoperative tumor differentiation, grading, and radiotherapy planning. Resection based on glioma metabolism information may provide for a more extensive resection and yield better outcomes for glioma patients. In this study, the authors attempt to integrate 3D (1)H-MRS into neuronavigation and assess the feasibility and validity of metabolically based glioma resection. METHODS Choline (Cho)-N-acetylaspartate (NAA) index (CNI) maps were calculated and integrated into neuronavigation. The CNI thresholds were quantitatively analyzed and compared with structural MRI studies. Glioma resections were performed under 3D (1)H-MRS guidance. Volumetric analyses were performed for metabolic and structural images from a low-grade glioma (LGG) group and high-grade glioma (HGG) group. Magnetic resonance imaging and neurological assessments were performed immediately after surgery and 1 year after tumor resection. RESULTS Fifteen eligible patients with primary cerebral gliomas were included in this study. Three-dimensional (1)H-MRS maps were successfully coregistered with structural images and integrated into navigational system. Volumetric analyses showed that the differences between the metabolic volumes with different CNI thresholds were statistically significant (p < 0.05). For the LGG group, the differences between the structural and the metabolic volumes with CNI thresholds of 0.5 and 1.5 were statistically significant (p = 0.0005 and 0.0129, respectively). For the HGG group, the differences between the structural and metabolic volumes with CNI thresholds of 0.5 and 1.0 were statistically significant (p = 0.0027 and 0.0497, respectively). All patients showed no tumor progression at the 1-year follow-up. CONCLUSIONS This study integrated 3D MRS maps and intraoperative navigation for glioma margin delineation. Optimum CNI thresholds were applied for both LGGs and HGGs to achieve resection. The results indicated that 3D (1)H-MRS can be integrated with structural imaging to provide better outcomes for glioma resection.

Entities:  

Keywords:  1H-MRS = proton MR spectroscopy; CNI = choline-NAA index; CSI = chemical shift imaging; Cho = choline; DICOM = digital imaging and communications in medicine; DTI = diffusion tensor imaging; EOR = extent of resection; GTR = gross-total resection; HGG = high-grade glioma; LGG = low-grade glioma; MPRAGE = magnetization-prepared rapid gradient-echo; NAA = N-acetylaspartate; OS = overall survival; PFS = progression-free survival; PT = pyramidal tract; ROI = region of interest; STR = subtotal resection; VOI = volume of interest; fMRI = functional MR imaging; glioma; magnetic resonance spectroscopy; neuronavigation; oncology; surgical planning

Mesh:

Substances:

Year:  2015        PMID: 26636387     DOI: 10.3171/2015.6.JNS142651

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

Review 1.  Current Clinical Brain Tumor Imaging.

Authors:  Javier E Villanueva-Meyer; Marc C Mabray; Soonmee Cha
Journal:  Neurosurgery       Date:  2017-09-01       Impact factor: 4.654

2.  Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.

Authors:  Sanjeev Chawla; Seung-Cheol Lee; Suyash Mohan; Sumei Wang; MacLean Nasrallah; Arastoo Vossough; Jaroslaw Krejza; Elias R Melhem; S Ali Nabavizadeh
Journal:  Neuroradiol J       Date:  2019-05-03

3.  Lesion segmentation for MR spectroscopic imaging using the convolution difference method.

Authors:  Andrew A Maudsley
Journal:  Magn Reson Med       Date:  2018-10-10       Impact factor: 4.668

4.  Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas.

Authors:  Tao He; Tianming Qiu; Xiaodong Wang; Hongxing Gui; Xilong Wang; Qikuan Hu; Hechun Xia; Gaoyang Qi; Jinsong Wu; Hui Ma
Journal:  Onco Targets Ther       Date:  2017-01-04       Impact factor: 4.147

5.  Integration of Three-dimensional Magnetic Resonance Imaging Spectroscopy with the Leksell GammaPlan Radiosurgical Planning Station for the Treatment of Brain Tumors.

Authors:  Fahd Derkaoui Hassani; Adyl Melhaoui; Younes Dif; Abdelhanine Oumoussa; Mohammed Jiddane; Yasser Arkha; Abdeslam El Khamlichi
Journal:  Cureus       Date:  2019-10-20

6.  Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.

Authors:  Niels Verburg; Thomas Koopman; Maqsood M Yaqub; Otto S Hoekstra; Adriaan A Lammertsma; Frederik Barkhof; Petra J W Pouwels; Jaap C Reijneveld; Jan J Heimans; Annemarie J M Rozemuller; Anne M E Bruynzeel; Frank Lagerwaard; William P Vandertop; Ronald Boellaard; Pieter Wesseling; Philip C de Witt Hamer
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

Review 7.  State-of-the-art imaging for glioma surgery.

Authors:  Niels Verburg; Philip C de Witt Hamer
Journal:  Neurosurg Rev       Date:  2020-06-30       Impact factor: 3.042

8.  Glioma Imaging by O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Diffusion-Weighted MRI and Correlation With Molecular Phenotypes, Validated by PET/MR-Guided Biopsies.

Authors:  Ye Cheng; Shuangshuang Song; Yukui Wei; Geng Xu; Yang An; Jie Ma; Hongwei Yang; Zhigang Qi; Xinru Xiao; Jie Bai; Lixin Xu; Zeliang Hu; Tingting Sun; Leiming Wang; Jie Lu; Qingtang Lin
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

9.  Intelligent SERS Navigation System Guiding Brain Tumor Surgery by Intraoperatively Delineating the Metabolic Acidosis.

Authors:  Ziyi Jin; Qi Yue; Wenjia Duan; An Sui; Botao Zhao; Yinhui Deng; Yuting Zhai; Yuwen Zhang; Tao Sun; Guang-Ping Zhang; Limei Han; Ying Mao; Jinhua Yu; Xiao-Yong Zhang; Cong Li
Journal:  Adv Sci (Weinh)       Date:  2022-01-12       Impact factor: 16.806

10.  Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner.

Authors:  Pavithra Viswanath; Marina Radoul; Jose Luis Izquierdo-Garcia; Hema Artee Luchman; J Gregory Cairncross; Russell O Pieper; Joanna J Phillips; Sabrina M Ronen
Journal:  Cancer Metab       Date:  2018-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.